These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 8307709)

  • 1. Hepatic microvascular regulatory mechanisms. XII. Effects of 5-HT2-receptor blockade on serotonin-induced intralobular hypoperfusion.
    Cummings JL; Cilento EV; Reilly FD
    Int J Microcirc Clin Exp; 1993 Oct; 13(2):99-112. PubMed ID: 8307709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic microvascular regulatory mechanisms. XI. Effects of serotonin on intralobular perfusion and volumetric flowrates at the inlet of periportal and outlet of centrivenous sinusoids.
    Blankenship LL; Cilento EV; Reilly FD
    Microcirc Endothelium Lymphatics; 1991; 7(1-3):57-75. PubMed ID: 1762610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic microvascular regulatory mechanisms. V. Effects of lodoxamide tromethamine or phentolamine-HCl on vascular responses elicited by serotonin.
    Reilly FD; Cilento EV; McCuskey RS
    Microcirc Endothelium Lymphatics; 1984 Dec; 1(6):671-89. PubMed ID: 6100792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic microvascular regulatory mechanisms. VIII. Glucogenic responses and morphologic changes following serotonin-induced low flow.
    Reilly FD; McCafferty RE; McCuskey PA; Dimlich RV
    Microcirc Endothelium Lymphatics; 1986; 3(1):21-46. PubMed ID: 3821692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic microvascular regulatory mechanisms. VII. Effects of endoportally-infused endotoxin on microcirculation and mast cells in rats.
    Unger LS; Reilly FD
    Microcirc Endothelium Lymphatics; 1986; 3(1):47-74. PubMed ID: 3547067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serotonin-induced contraction in porcine coronary artery: use of ergolines to support vascular 5-hydroxytryptamine2-receptor heterogeneity.
    Cushing DJ; Cohen ML
    J Pharmacol Exp Ther; 1993 Jan; 264(1):193-200. PubMed ID: 8423526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serotonin-induced pulmonary responses are mediated by the 5-HT2 receptor in the mouse.
    Martin TR; Cohen ML; Drazen JM
    J Pharmacol Exp Ther; 1994 Jan; 268(1):104-9. PubMed ID: 8301545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic microvascular regulatory mechanisms. IX. Effects of compound 48/80 on endotoxin-induced changes in microcirculation and mast cell integrity.
    Unger LS; Reilly FD
    Microcirc Endothelium Lymphatics; 1986; 3(2):109-28. PubMed ID: 3587176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LY53857, a selective and potent serotonergic (5-HT2) receptor antagonist, does not lower blood pressure in the spontaneously hypertensive rat.
    Cohen ML; Fuller RW; Kurz KD
    J Pharmacol Exp Ther; 1983 Nov; 227(2):327-32. PubMed ID: 6313898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-HT2-receptor antagonists: alpha 1- vs. 5-HT2-receptor blocking properties in blood vessels.
    Cohen ML; Schenck KW; Kurz KD
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S25-9. PubMed ID: 2459510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic microvascular regulatory mechanisms. VI. Effects of lodoxamide tromethamine or phentolamine-HCl on early hemodynamic and glucoregulatory alterations evoked by endotoxin.
    Reilly FD; Dimlich RV
    Microcirc Endothelium Lymphatics; 1985 Jun; 2(3):271-92. PubMed ID: 3836345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-HT activates vagal afferent cell bodies in vivo: role of 5-HT2 and 5-HT3 receptors.
    Lacolley P; Owen JR; Sandock K; Lewis TH; Bates JN; Robertson TP; Lewis SJ
    Neuroscience; 2006 Nov; 143(1):273-87. PubMed ID: 17029799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the serotonin receptors that mediate smooth muscle contraction in canine and porcine coronary artery.
    Cushing DJ; Cohen ML
    J Pharmacol Exp Ther; 1992 Jun; 261(3):856-62. PubMed ID: 1602389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic microvascular regulatory mechanisms. X. Effects of alpha-one or -two adrenoceptor blockade on glucoregulation in normotensive endotoxic rats with optimal perfusion and flowrates.
    Reilly FD; McCafferty RE; Cilento EV
    Microcirc Endothelium Lymphatics; 1988 Aug; 4(4):293-309. PubMed ID: 2906736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical pharmacology of a new serotonergic receptor antagonist, LY281067.
    Cohen ML; Fuller RW; Kurz KD; Parli CJ; Mason NR; Meyers DB; Smallwood JK; Toomey RE
    J Pharmacol Exp Ther; 1988 Jan; 244(1):106-12. PubMed ID: 3335993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participation of cyclooxygenase pathway in the vasoconstriction induced by 5-HT in the in situ autoperfused kidney of long-term diabetic rats.
    Restrepo B; García M; Rodríguez-Barbero A; Román LS; Martin ML; Morán A
    Eur J Pharmacol; 2011 May; 659(1):37-44. PubMed ID: 21414306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LY215840, a potent 5-hydroxytryptamine (5-HT)2 receptor antagonist, blocks vascular and platelet 5-HT2 receptors and delays occlusion in a rabbit model of thrombosis.
    Cohen ML; Robertson DW; Bloomquist WE; Wilson HC
    J Pharmacol Exp Ther; 1992 Apr; 261(1):202-8. PubMed ID: 1560366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic microvascular regulatory mechanisms. III. Aminergic mechanisms as related to mast cells.
    Reilly FD; Dimlich RV; Cilento EV; McCuskey RS
    Int J Microcirc Clin Exp; 1983; 2(1):61-73. PubMed ID: 6678839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LY215840, a high-affinity 5-HT7 receptor ligand, blocks serotonin-induced relaxation in canine coronary artery.
    Cushing DJ; Zgombick JM; Nelson DL; Cohen ML
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1560-6. PubMed ID: 8667223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Central stimulation of renin secretion through serotonergic, noncardiovascular mechanisms.
    Rittenhouse PA; Bakkum EA; Levy AD; Li Q; Yracheta JM; Kunimoto K; van de Kar LD
    Neuroendocrinology; 1994 Aug; 60(2):205-14. PubMed ID: 7969778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.